Two more doctoral researchers in KEMAI are now part of the International Graduate School in Molecular Medicine (IGradU):
Atif Khurschid and Michael Glöckler have successfully passed the IGradU Selection Day on July 28, 2025.
They will be admitted to the 3-year doctoral program for winter term 2025/26.